Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Sep
1
2015
Wait Continues for Release of First FSMA Final Rules Armstrong Teasdale
Jan
8
2018
Agribusiness and Food Issues to Watch for 2018 Armstrong Teasdale
Jun
24
2015
Deadlines for FSMA Final Rules Loom -- Keep Your Eye on the FDA Armstrong Teasdale
May
7
2016
FDA Extends Regulatory Authority Over All Tobacco Products, Including E-Cigarettes, Cigars and Hookahs Armstrong Teasdale
Jul
9
2016
Terrorism Regulations Finish FDA's FSMA Implementation Armstrong Teasdale
Sep
11
2015
FDA Warning Letter Says Vegan Mayonnaise Can’t be Labeled Mayo Armstrong Teasdale
Aug
13
2014
Biotechnology/Pharma Patents: Immune to Post Grant Challenges? Armstrong Teasdale
Jan
17
2016
Agriculture, Food, and Health Issues to Watch for 2016 Armstrong Teasdale
Nov
11
2016
Voters Approve New Marijuana Laws in Eight States Armstrong Teasdale
Mar
17
2014
Innovator Liability Theory Gets Traction in the Northern District of Illinois Armstrong Teasdale
Oct
20
2014
IPR (Inter Partes Review) Challenge to Pharmaceutical Compound Patent Denied Armstrong Teasdale
Nov
13
2015
FDA Requests Public Comment on "Natural" Food Labels Armstrong Teasdale
Jul
7
2014
First Written Decision Pertaining to Pharmaceuticals Armstrong Teasdale
Mar
8
2015
Lawsuits Against Endoscope Manufacturers and Health Care Facilities to Increase Following UCLA’s “Superbug” Outbreak Armstrong Teasdale
Nov
30
2015
Food Safety and Inspection Service Issues New Allergen Handling Guidelines Barnes & Thornburg LLP
Jan
12
2016
FDA Issues Draft Guidance on Emerging Signals for Medical Devices Barnes & Thornburg LLP
May
17
2016
FDA Issues Draft Guidance on Additive Manufacturing Including 3D Printing Barnes & Thornburg LLP
Apr
16
2018
Congress Takes on Opioid Epidemic, Aims to Provide Tools for Public Health Barnes & Thornburg LLP
Jul
12
2013
Senate Bill Would Increase Pipeline and Hazardous Materials Safety Administration (PHMSA) Budget by Over 12 Percent Barnes & Thornburg LLP
Aug
16
2013
New All Appropriate Inquiries (ASTM) Phase 1 Environmental Site Assessment Standards Endorsed by EPA as Constituting “All Appropriate Inquiries” under Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) Barnes & Thornburg LLP
Jul
3
2018
FDA Issues First Installment Of Guidance On ‘Mitigation Strategies To Protect Food Against Intentional Adulteration’ Rule Barnes & Thornburg LLP
Jan
3
2019
2018 Year-End FDA Medical Device Highlights Include Proposed Changes Barnes & Thornburg LLP
Feb
22
2019
Insurance Coverage for Defendants Named in Nationwide Opioid Litigation Barnes & Thornburg LLP
Oct
21
2014
FDA Issues Final Guidance on Distinguishing Medical Device Recall from Product Enhancement Barnes & Thornburg LLP
Dec
18
2014
2014 Interim Guidance on Patent Subject Matter Eligibility Under Myriad and Nature-Based Products Barnes & Thornburg LLP
Jan
20
2015
FDA Issues Draft Guidance on Policy for Low Risk Devices for General Wellness Barnes & Thornburg LLP
Mar
7
2023
HHS-OIG Foregoes Sanctions On Drug Manufacturer For Providing Free Drugs To Patients Waiting For Insurance Authorization Barnes & Thornburg LLP
Jul
27
2015
FDA Issues Proposed Rule and Draft Guidance on User Fee Program for Accreditation of Third-Party Auditors-Certification Bodies to Conduct Food Safety Audits and To Issue Certifications Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins